| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.2 | 0.03 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.04 |